Singapore to be GSK’s base for growth in Asia

 12-Mar-15, Today

Pharmaceutical giant GlaxoSmithKline (GSK) announced yesterday that it will use Singapore as a base to steer its growth in Asia, with the set-up of a new regional headquarters here.

Image: Reuters

The eight-storey facility, with an area of almost 15,000 sq m, will be located in One-North. Construction is expected to be completed by the end of next year. The headquarters can house up to 1,000 employees across its pharmaceutical, vaccine and consumer healthcare businesses.

GSK, which has more than 700 office-based staff here, expects to add another 100 positions to its payroll in Singapore as the facility nears completion, and has transferred almost 150 global or regional roles to the country over the past year.

 Read the full article

 Insights